Atlas Trials

S-1 IMRT Versus S-1 and Cisplatin Concurrent IMRT in Inoperable Esophageal Squamous Cell Carcinoma

Clinical trial NCT02913066 · UNKNOWN

Trial details

NCT number
NCT02913066
Sponsor
Mianyang Central Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Esophageal Squamous Cell Carcinoma
Start date
2016-09-01
Primary completion
2019-03-01
Enrollment
88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.